Cytora Reports Phase 1 Data of Stem Cell Treatment for Multiple System Atrophy
Cytora, a clinical stage company developing unique stem cell treatments based on human Oral Mucosa Stem Cells (hOMSC), reported today data of an ongoing Phase 1 clinical study for treating...

